Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tazarotene gel may be more effective for acne than adapalene gel.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.